Flow cytometry is a laser-based, biotechnology tool used for analyzing characteristics of biological entities such as cells, chromosomes, and proteins. Flow cytometry allows identifying and counting different cell populations within a mixture based on the specific proteins or molecular structures present on the surfaces or inside the cells. It helps in detection and monitoring of diseases by examining changes in DNA, RNA, and protein expression and distribution within biological samples.

The global flow cytometry market is estimated to be valued at US$ 5 billion in 2024 and is expected to exhibit a CAGR of 10% over the forecast period 2024 to 2030.

Key Takeaways

Key players operating in the flow cytometry market are BD, Beckman Coulter, Merck KGaA, Agilent Technologies, Luminex, and Thermo Fisher Scientific.

The key opportunities in the Flow Cytometry Market Trends include increasing funding and investments for cancer research along with growth of stem cell research. Furthermore, technological advancements enabling high-throughput screening and multi-parameter analysis are also boosting the market growth.

Technological advancements such as expansion of parameters for detection, development of novel fluorescent dyes, reagents and antibodies, introduction of compact analyzers, and advancement in data analysis software are driving the adoption of flow cytometry in research and clinical applications.

Market Drivers

Increasing prevalence of chronic and infectious diseases along with rising healthcare expenditure is a major factor driving the adoption of flow cytometry. It is widely used for disease diagnostics and monitoring in cancer, HIV/AIDS, and rare blood disorders. Growing biopharmaceutical and biotechnology industry is also augmenting the demand for flow cytometry in drug discovery and development applications. In addition, increasing government funding for life science research along with rising stem cell research activities are fueling the market growth.

Get More Insights on- Flow Cytometry Market